Seminars in Nephrology
Volume 28, Issue 3 , Pages 297-305 , May 2008

Aquaporin 2 and Apical Calcium-Sensing Receptor: New Players in Polyuric Disorders Associated With Hypercalciuria

  • G. Procino, PhD

      Affiliations

    • Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics, University of Bari, Bari, Italy
    • ,
  • L. Mastrofrancesco

      Affiliations

    • Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics, University of Bari, Bari, Italy
    • ,
  • A. Mira, PhD

      Affiliations

    • Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics, University of Bari, Bari, Italy
    • ,
  • G. Tamma, PhD

      Affiliations

    • Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics, University of Bari, Bari, Italy
    • ,
  • M. Carmosino, PhD

      Affiliations

    • Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics, University of Bari, Bari, Italy
    • ,
  • F. Emma, MD

      Affiliations

    • Department of Nephrology and Urology, Division of Nephrology and Dialysis, Bambino Gesù Children's Hospital, Rome, Italy
    • ,
  • M. Svelto, PhD

      Affiliations

    • Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics, University of Bari, Bari, Italy
    • ,
  • G. Valenti, PhD

      Affiliations

    • Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics, University of Bari, Bari, Italy
    • Corresponding Author InformationAddress reprint requests to G. Valenti, Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics, University of Bari, Bari, Italy.

References 

  1. Taylor EN, Curhan GC. Diet and fluid prescription in stone disease. Kidney Int. 2006;70:835–839
  2. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115:2598–2608
  3. Gambaro G, Vezzoli G, Casari G, et al. Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis. 2004;44:963–986
  4. Moe OW, Bonny O. Genetic hypercalciuria. >J Am Soc Nephrol. 2005;16:729–745
  5. Devuyst O, Pirson Y. Genetics of hypercalciuric stone forming diseases. Kidney Int. 2007;72:1065–1072
  6. Asplin JR, Mandel NS, Coe FL. Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol. 1996;270:F604–F613
  7. Johnson CM, Wilson DM, O'Fallon WM, et al. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16:624–631
  8. Verkoelen CF, Verhulst A. Proposed mechanisms in renal tubular crystal retention. Kidney Int. 2007;72:13–18
  9. Jacobson AL, Singhal PC, Mandin H, et al. Urinary ionic calcium and binding sites in normocalciuric idiopathic calcium urolithiasis. Invest Urol. 1979;17:218–222
  10. Strauss AL, Coe FL, Deutsch L, et al. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982;72:17–24
  11. Knepper MA, Inoue T. Regulation of aquaporin-2 water channel trafficking by vasopressin. Curr Opin Cell Biol. 1997;9:560–564
  12. Klussmann E, Maric K, Rosenthal W. The mechanisms of aquaporin control in the renal collecting duct. Rev Physiol Biochem Pharmacol. 2000;141:33–95
  13. Brown D. The ins and outs of aquaporin-2 trafficking. Am J Physiol Renal Physiol. 2003;284:F893–F901
  14. Valenti G, Procino G, Tamma G, et al. Minireview: aquaporin 2 trafficking. Endocrinology. 2005;146:5063–5070
  15. Knoers NV, Deen PM. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol. 2001;16:1146–1152
  16. Procino G, Carmosino M, Marin O, et al. Ser-256 phosphorylation dynamics of aquaporin 2 during maturation from the ER to the vesicular compartment in renal cells. FASEB J. 2003;17:1886–1888
  17. Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics. 2006;5:1760–1771
  18. Kanno K, Sasaki S, Hirata Y, et al. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med. 1995;332:1540–1545
  19. Deen PM, van Aubel RA, van Lieburg AF, et al. Urinary content of aquaporin 1 and 2 in nephrogenic diabetes insipidus. J Am Soc Nephrol. 1996;7:836–841
  20. Saito T, Ishikawa SE, Sasaki S, et al. Alteration in water channel AQP-2 by removal of AVP stimulation in collecting duct cells of dehydrated rats. Am J Physiol. 1997;272:F183–F191
  21. Murer L, Addabbo F, Carmosino M, et al. Selective decrease in urinary aquaporin 2 and increase in prostaglandin E2 excretion is associated with postobstructive polyuria in human congenital hydronephrosis. J Am Soc Nephrol. 2004;15:2705–2712
  22. Ishikawa S. Urinary excretion of aquaporin-2 in pathological states of water metabolism. Ann Med. 2000;32:90–93
  23. Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 2006;17:1820–1832
  24. Valenti G, Laera A, Pace G, et al. Urinary aquaporin 2 and calciuria correlate with the severity of enuresis in children. J Am Soc Nephrol. 2000;11:1873–1881
  25. Shaer AJ. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes. Am J Med Sci. 2001;322:316–332
  26. Sands JM, Naruse M, Baum M, et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest. 1997;99:1399–1405
  27. Sands JM, Flores FX, Kato A, et al. Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats. Am J Physiol. 1998;274:F978–F985
  28. Puliyanda DP, Ward DT, Baum MA, et al. Calpain-mediated AQP2 proteolysis in inner medullary collecting duct. Biochem Biophys Res Commun. 2003;303:52–58
  29. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev. 2001;81:239–297
  30. Ward DT, Riccardi D. Renal physiology of the extracellular calcium-sensing receptor. Pflugers Arch. 2002;445:169–176
  31. Hebert SC, Brown EM, Harris HW. Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis. J Exp Biol. 1997;200:295–302
  32. Pearce SH, Thakker RV. The calcium-sensing receptor: insights into extracellular calcium homeostasis in health and disease. J Endocrinol. 1997;154:371–378
  33. Hofer AM, Brown EM. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol. 2003;4:530–538
  34. Alon US. Nocturnal enuresis. Pediatr Nephrol. 1995;9:94–103
  35. Mark SD, Frank JD. Nocturnal enuresis. Br J Urol. 1995;75:427–434
  36. Pace G, Aceto G, Cormio L, et al. Nocturnal enuresis can be caused by absorptive hypercalciuria. Scand J Urol Nephrol. 1999;33:111–114
  37. Valenti G, Laera A, Gouraud S, et al. Low-calcium diet in hypercalciuric enuretic children restores AQP2 excretion and improves clinical symptoms. Am J Physiol Renal Physiol. 2002;283:F895–F903
  38. Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 1993;366:575–580
  39. Riccardi D, Lee WS, Lee K, et al. Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol. 1996;271:F951–F956
  40. Riccardi D, Park J, Lee WS, et al. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A. 1995;92:131–135
  41. Brown EM. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med. 1999;106:238–253
  42. Brown EM, Chattopadhyay N, Vassilev PM, et al. The calcium-sensing receptor (CaR) permits Ca2+ to function as a versatile extracellular first messenger. Recent Prog Horm Res. 1998;53:257–281
  43. Procino G, Carmosino M, Tamma G, et al. Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells. Kidney Int. 2004;66:2245–2255
  44. Valenti G, Frigeri A, Ronco PM, et al. Expression and functional analysis of water channels in a stably AQP2-transfected human collecting duct cell line. J Biol Chem. 1996;271:24365–24370
  45. Bustamante M, Hasler U, Leroy V. Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulin-dependent mechanism. J Am Soc Nephrol. 2008;19:109–116
  46. Hasler U, Mordasini D, Bens M, et al. Long term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem. 2002;277:10379–10386
  47. Bai M. Structure-function relationship of the extracellular calcium-sensing receptor. Cell Calcium. 2004;35:197–207
  48. Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol. 1996;271:C103–C111
  49. Pollak MR, Brown EM, Chou YH, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 1993;75:1297–1303
  50. Ho DS, Jerkins GR, Williams M, et al. Ureteropelvic junction obstruction in upper and lower moiety of duplex renal systems. Urology. 1995;45:503–506
  51. Bai M, Quinn S, Trivedi S, et al. Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem. 1996;271:19537–19545
  52. Pollak MR, Brown EM, Estep HL, et al. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet. 1994;8:303–307
  53. Pearce SH, Williamson C, Kifor O, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med. 1996;335:1115–1122
  54. Hendy GN, D'Souza-Li L, Yang B, et al. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat. 2000;16:281–296
  55. Bai M, Janicic N, Trivedi S, et al. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest. 1997;99:1917–1925
  56. Lienhardt A, Garabedian M, Bai M, et al. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab. 2000;85:1695–1702
  57. Marx SJ, Attie MF, Stock JL, et al. Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab. 1981;52:736–740
  58. Vargas-Poussou R, Huang C, Hulin P, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol. 2002;13:2259–2266
  59. Vezzoli G, Terranegra A, Arcidiacono T, et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 2007;71:1155–1162
  60. Vezzoli G, Tanini A, Ferrucci L, et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol. 2002;13:2517–2523
  61. Hodgkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg. 1958;46:10–18
  62. Petrel C, Kessler A, Dauban P, et al. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem. 2004;279:18990–18997
  63. Gowen M, Stroup GB, Dodds RA, et al. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest. 2000;105:1595–1604
  64. Dvorak MM, Siddiqua A, Ward DT, et al. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A. 2004;101:5140–5145

 Supported by grants from Telethon (GGP04202 to G.V.), PRIN (Research Program of National Interest to G.V.), Centro di Eccellenza di Genomica in campo Biomedico ed Agrario (CEGBA), and from the Regional Project 2007 (G.V.).

PII: S0270-9295(08)00051-X

doi: 10.1016/j.semnephrol.2008.03.007

Seminars in Nephrology
Volume 28, Issue 3 , Pages 297-305 , May 2008

Article Tools

* Image Usage & Resolution